GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (STU:ZSB) » Definitions » Piotroski F-Score

Sirona Biochem (STU:ZSB) Piotroski F-Score : 1 (As of Apr. 28, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Sirona Biochem Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 1 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sirona Biochem has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Sirona Biochem's Piotroski F-Score or its related term are showing as below:

STU:ZSB' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 3   Max: 5
Current: 1

During the past 13 years, the highest Piotroski F-Score of Sirona Biochem was 5. The lowest was 1. And the median was 3.


Sirona Biochem Piotroski F-Score Historical Data

The historical data trend for Sirona Biochem's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem Piotroski F-Score Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 4.00 2.00 4.00 2.00

Sirona Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 3.00 2.00 2.00 1.00

Competitive Comparison of Sirona Biochem's Piotroski F-Score

For the Biotechnology subindustry, Sirona Biochem's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirona Biochem's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirona Biochem's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Sirona Biochem's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jan24) TTM:Last Year (Jan23) TTM:
Net Income was -0.517 + -0.36 + -0.436 + -0.501 = €-1.81 Mil.
Cash Flow from Operations was -0.514 + -0.369 + -0.167 + -0.371 = €-1.42 Mil.
Revenue was 0.041 + 0.005 + -0.022 + 0.001 = €0.03 Mil.
Gross Profit was 0.041 + 0.005 + -0.022 + 0.001 = €0.03 Mil.
Average Total Assets from the begining of this year (Jan23)
to the end of this year (Jan24) was
(0.538 + 0.944 + 0.755 + 0.713 + 0.479) / 5 = €0.6858 Mil.
Total Assets at the begining of this year (Jan23) was €0.54 Mil.
Long-Term Debt & Capital Lease Obligation was €1.06 Mil.
Total Current Assets was €0.48 Mil.
Total Current Liabilities was €1.23 Mil.
Net Income was -0.614 + -0.29 + -0.27 + -0.43 = €-1.60 Mil.

Revenue was 0.14 + 0.497 + 0.013 + 0 = €0.65 Mil.
Gross Profit was 0.14 + 0.497 + 0.013 + 0 = €0.65 Mil.
Average Total Assets from the begining of last year (Jan22)
to the end of last year (Jan23) was
(0.473 + 1.486 + 1.487 + 0.957 + 0.538) / 5 = €0.9882 Mil.
Total Assets at the begining of last year (Jan22) was €0.47 Mil.
Long-Term Debt & Capital Lease Obligation was €0.08 Mil.
Total Current Assets was €0.53 Mil.
Total Current Liabilities was €0.62 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sirona Biochem's current Net Income (TTM) was -1.81. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sirona Biochem's current Cash Flow from Operations (TTM) was -1.42. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jan23)
=-1.814/0.538
=-3.37174721

ROA (Last Year)=Net Income/Total Assets (Jan22)
=-1.604/0.473
=-3.39112051

Sirona Biochem's return on assets of this year was -3.37174721. Sirona Biochem's return on assets of last year was -3.39112051. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Sirona Biochem's current Net Income (TTM) was -1.81. Sirona Biochem's current Cash Flow from Operations (TTM) was -1.42. ==> -1.42 > -1.81 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jan24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jan23 to Jan24
=1.064/0.6858
=1.55147273

Gearing (Last Year: Jan23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jan22 to Jan23
=0.077/0.9882
=0.07791945

Sirona Biochem's gearing of this year was 1.55147273. Sirona Biochem's gearing of last year was 0.07791945. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jan24)=Total Current Assets/Total Current Liabilities
=0.475/1.23
=0.38617886

Current Ratio (Last Year: Jan23)=Total Current Assets/Total Current Liabilities
=0.527/0.622
=0.84726688

Sirona Biochem's current ratio of this year was 0.38617886. Sirona Biochem's current ratio of last year was 0.84726688. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Sirona Biochem's number of shares in issue this year was 253.605. Sirona Biochem's number of shares in issue last year was 251.784. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.025/0.025
=1

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.65/0.65
=1

Sirona Biochem's gross margin of this year was 1. Sirona Biochem's gross margin of last year was 1. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jan23)
=0.025/0.538
=0.0464684

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jan22)
=0.65/0.473
=1.37420719

Sirona Biochem's asset turnover of this year was 0.0464684. Sirona Biochem's asset turnover of last year was 1.37420719. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+0+0+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sirona Biochem has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Sirona Biochem  (STU:ZSB) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Sirona Biochem Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirona Biochem (STU:ZSB) Business Description

Traded in Other Exchanges
Address
C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Sirona Biochem (STU:ZSB) Headlines

No Headlines